Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Payables (2016 - 2025)

Historic Payables for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $636237.0.

  • Silo Pharma's Payables fell 3459.26% to $636237.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $636237.0, marking a year-over-year decrease of 3459.26%. This contributed to the annual value of $1.6 million for FY2024, which is 12514.88% up from last year.
  • Per Silo Pharma's latest filing, its Payables stood at $636237.0 for Q3 2025, which was down 3459.26% from $977795.0 recorded in Q2 2025.
  • Over the past 5 years, Silo Pharma's Payables peaked at $1.6 million during Q4 2024, and registered a low of $153601.0 during Q1 2022.
  • Moreover, its 5-year median value for Payables was $621453.0 (2023), whereas its average is $650375.9.
  • In the last 5 years, Silo Pharma's Payables tumbled by 3996.98% in 2022 and then skyrocketed by 57218.0% in 2023.
  • Quarter analysis of 5 years shows Silo Pharma's Payables stood at $417937.0 in 2021, then dropped by 12.85% to $364216.0 in 2022, then soared by 93.15% to $703488.0 in 2023, then surged by 125.15% to $1.6 million in 2024, then plummeted by 59.83% to $636237.0 in 2025.
  • Its Payables stands at $636237.0 for Q3 2025, versus $977795.0 for Q2 2025 and $1.1 million for Q1 2025.